Table 3.

Onset of New Symptoms After SRS

	All N = 705	Tumor progression N = 107	Tumor control N = 598	P-value
Onset of new symptoms after SRS	72 (10.2%)	22 (20.6%)	50 (8.4%)	<.001
Facial nerve affection	54 (7.7%)	19 (17.8%)	35 (5.9%)	<.001
Facial palsy	11 (1.6%)	0	11 (1.8%)	.157
Hemifacial spasm	41 (5.8%)	17 (15.9%)	24 (4.0%)	<.001
Hydrocephalus	2 (0.3%)	2 (1.9%)	0	.023
Brainstem edema	1 (0.1%)	1 (0.9%)	1(0.2%)	.169

P-values indicate significant differences. Values are presented as the number of patients (%) and mean ± SD, unless indicated otherwise. Significant P-values (<.05) are highlighted in italics.